skip to main content

Research + Education

The University of Michigan Rogel Cancer Center has a distinguished history of scientific excellence, collaboration and impact in basic science, clinical research and cancer control research.


  • Rogel Cancer Center attends ASCO's annual meeting

    Rogel Cancer Center faculty and trainees will lead two dozen presentations, posters and moderated sessions at the American Society for Clinical Oncology annual meeting. This year’s meeting will be held in-person and online. View the schedule of presentations and poster sessions.
    Read More >
  • Experts discuss advances in thyroid cancer diagnosis and treatment

    After years in the shadow of more common cancers, there’s new light for patients with thyroid cancer. Increased use of neck ultrasounds has driven up the number of people globally who are diagnosed with thyroid cancer, which has brought new attention to the disease. It’s now the ninth most common cancer worldwide.
    Read More >
  • Researchers discover cancer cells use a new fuel in absence of sugar

    Researchers at the University of Michigan Rogel Cancer Center have discovered a new nutrient source that pancreatic cancer cells use to grow. The molecule, uridine, offers insight into both biochemical processes and possible therapeutic pathways.
    Read More >
  • Combatting critical drug shortages

    Andrew Shuman, M.D., FACS, HEC-C, chief of the clinical ethics service in Michigan Medicine’s Center for Bioethics and Social Sciences, recently testified before the Homeland Security and Governmental Affairs Committee for the United States Senate regarding critical drug shortages.
    Read More >